Embecta Corp
Research Embecta Corp (EMBC) on Bullrun: market cap USD 285.00M, P/E 3.4, dividend yield 6.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEMBC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 285.00M
- P/E3.4
- Dividend yield6.2%
- Financial periodQ2 2026
- RevenueUSD 271.70M
- Net incomeUSD 21.10M
- Free cash flowUSD 40.70M
- Gross margin56.4%
Valuation Snapshot
latest market cap is USD 285.00M; P/E is 3.4; dividend yield is 6.2%.
Peer valuation comparison
Latest P/E is 3.39x versus a Healthcare sector median of 24.46x (86.1% below).
Latest dividend yield is 6.24% versus a Healthcare sector median of 2.11% (195.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.08B | USD 95.40M | USD 182.40M | 62.6% | 1.62 | USD 225.50M | USD 1.40B | -USD 650.60M |
| FY2024 | USD 1.12B | USD 78.30M | USD 19.90M | 65.5% | 1.34 | USD 267.50M | USD 1.57B | -USD 738.30M |
| FY2023 | USD 1.12B | USD 70.40M | USD 41.20M | 66.9% | 1.22 | USD 326.30M | USD 1.60B | -USD 821.70M |
| FY2022 | USD 1.13B | USD 223.60M | USD 388.60M | 68.6% | 3.89 | USD 330.90M | USD 1.61B | -USD 891.40M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 285.00M | 3.4 | 9.1% | 0.46 |
| 2025 | 2025-12-31 | USD 703.44M | 5.0 | 5.1% | 0.6 |
| 2024 | 2024-12-31 | USD 1.20B | 20.4 | 2.9% | 0.6 |
| 2023 | 2023-12-29 | USD 1.09B | 15.4 | 3.2% | 0.6 |
| 2022 | 2022-12-30 | USD 1.45B | 6.5 | 1.2% | 0.3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.46 USD, yield 6.2%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.6 USD |
| FY2024 | 0.6 USD |
| FY2023 | 0.6 USD |
| FY2022 | 0.15 USD |
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Embecta Corp's market cap?
Embecta Corp's market capitalization is USD 285.00M.
What is Embecta Corp's P/E ratio?
Embecta Corp's price-to-earnings (P/E) ratio is 3.4.
Does Embecta Corp pay a dividend?
Embecta Corp has a dividend yield of 6.2%.
What does Embecta Corp do?
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.